 |
|
Mechanisms Involved with Tumor Relapse Identified
March 14, 2007Researchers work toward creating a tailored breast cancer vaccine
Researchers at Virginia Commonwealth University's Massey Cancer Center studying the interaction between the immune system and cancer cells have identified interferon gamma as one of the signaling proteins involved with tumor relapse.
The findings may help researchers develop tailored vaccines and other immunotherapeutic strategies to fight a number of cancers. Immunotherapy involves the manipulation of the immune system - by introducing an antibody or lymphocytes, or immunization with a tumor vaccine - to recognize and eradicate tumor cells.
Using a transgenic mouse model of breast cancer, researchers found that interferon gamma, a cytokine or chemical messenger that is produced by cells of the immune system upon activation, plays a role in tumor relapse. In humans, interferon gamma is also produced by white blood cells of the immune system in response to invasion by pathogens or tumors in order to protect the host against infection or cancers. Production of interferon gamma by lymphocytes against tumors is considered a sign of good prognosis; however, recent study findings indicate that this may not be the case. The findings were reported in the March 2007 issue of the European Journal of Immunology, the official journal of the European Federation of Immunological Societies.
"By understanding the molecular mechanisms involved with tumor relapse, we can create tailored vaccines that can induce specific types of immune responses in patients, rather than inducing a broad range of immune responses-some of which may be detrimental or may induce tumor relapse," said lead investigator, Masoud H. Manjili, D.V.M., Ph.D., a member scientist with the Massey Cancer Center.
"Ultimately, we hope to offer a new polypeptide vaccine approach that induces tumor killing without causing HER-2/neu loss. Loss of HER-2/neu is a mechanism that tumors utilize to escape the immune-mediated destruction," he said.
Since 2000, Manjili and his colleagues have been employing animal models of breast cancer to evaluate anti-tumor efficacy of a vaccine formulation they created. This vaccine formulation combines a heat shock protein 110 (HSP110), as an adjuvant, with a tumor antigen HER-2/neu, as a protein target expressed in breast tumors. Adjuvants are agents that are able to modify another agent - basically working as a chemical catalyst.
The work is supported by the National Cancer Institute and the Susan G. Komen Breast Cancer Foundation.
Manjili, who is an assistant professor in the Department of Microbiology and Immunology in the VCU School of Medicine, collaborated with VCU researchers Maciej Kmieciak, Ph.D., with the Department of Microbiology and Immunology, and Catherine I. Dumur, Ph.D., with the Department of Pathology; and Keith L. Knutson, Ph.D., with the Department of Immunology at the Mayo Clinic College of Medicine in Rochester, Minn.
Virginia Commonwealth University
Using a transgenic mouse model of breast cancer, researchers found that interferon gamma, a cytokine or chemical messenger that is produced by cells of the immune system upon activation, plays a role in tumor relapse. In humans, interferon gamma is also produced by white blood cells of the immune system in response to invasion by pathogens or tumors in order to protect the host against infection or cancers. Production of interferon gamma by lymphocytes against tumors is considered a sign of good prognosis; however, recent study findings indicate that this may not be the case. The findings were reported in the March 2007 issue of the European Journal of Immunology, the official journal of the European Federation of Immunological Societies.
"By understanding the molecular mechanisms involved with tumor relapse, we can create tailored vaccines that can induce specific types of immune responses in patients, rather than inducing a broad range of immune responses-some of which may be detrimental or may induce tumor relapse," said lead investigator, Masoud H. Manjili, D.V.M., Ph.D., a member scientist with the Massey Cancer Center.
"Ultimately, we hope to offer a new polypeptide vaccine approach that induces tumor killing without causing HER-2/neu loss. Loss of HER-2/neu is a mechanism that tumors utilize to escape the immune-mediated destruction," he said.
Since 2000, Manjili and his colleagues have been employing animal models of breast cancer to evaluate anti-tumor efficacy of a vaccine formulation they created. This vaccine formulation combines a heat shock protein 110 (HSP110), as an adjuvant, with a tumor antigen HER-2/neu, as a protein target expressed in breast tumors. Adjuvants are agents that are able to modify another agent - basically working as a chemical catalyst.
The work is supported by the National Cancer Institute and the Susan G. Komen Breast Cancer Foundation.
Manjili, who is an assistant professor in the Department of Microbiology and Immunology in the VCU School of Medicine, collaborated with VCU researchers Maciej Kmieciak, Ph.D., with the Department of Microbiology and Immunology, and Catherine I. Dumur, Ph.D., with the Department of Pathology; and Keith L. Knutson, Ph.D., with the Department of Immunology at the Mayo Clinic College of Medicine in Rochester, Minn.
Virginia Commonwealth University
Tumor Current Events and Tumor News RSSOther Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers Say
A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer.
Rare pancreatic cancer patients may live longer when treated with radiation therapy
Radiation therapy is effective in achieving local control and palliation in patients with pancreatic neuroendocrine tumors (PNTs), despite such tumors being commonly considered resistant to radiation therapy.
Researchers Identify Role of Gene in Tumor Development, Growth and Progression
Virginia Commonwealth University Massey Cancer Center and VCU Institute of Molecular Medicine researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis.
Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer
Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene.
New cancer target for non-Hodgkin's lymphoma
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, or white blood cells.
Laser therapy can aggravate skin cancer
High irradiances of low-level laser therapy (LLLT) should not be used over melanomas.
Common pain relief medication may encourage cancer growth
Although morphine has been the gold-standard treatment for postoperative and chronic cancer pain for two centuries, a growing body of evidence is showing that opiate-based painkillers can stimulate the growth and spread of cancer cells.
Cancers' Sweet Tooth May Be Weakness
The pedal-to-the-metal signals driving the growth of several types of cancer cells lead to a common switch governing the use of glucose, researchers at Winship Cancer Institute of Emory University have discovered.
UCLA researchers create 'fly paper' to capture circulating cancer cells
Just as fly paper captures insects, an innovative new device with nano-sized features developed by researchers at UCLA is able to grab cancer cells in the blood that have broken off from a tumor.
'Cross-talk' mechanism contributes to colorectal cancer
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have identified a molecular mechanism that allows two powerful signaling pathways to interact and begin a process leading to colorectal tumors.
More Tumor Current Events and Tumor News Articles
|
Tumor by Joshua Hale Fialkov (Author), Noel Tuazon (Author) From the Harvey Award-nominated creative team of Elk's Run comes Tumor, the critically acclaimed sensation that was the first graphic novel to debut exclusively on the Kindle E-Book Reader! Tumor is the story of Frank Armstrong, a man at the boot heel of the world, barely scraping up a living as a private investigator in modern day Los Angeles. He finally lands a big case, finding the missing daughter of a drug kingpin, just as he's taken by the symptoms of a late-stage brain tumor. Memories blend with reality, as the missing girl case starts to seep into the memory of his own missing wife from 20 years prior. Now, with days, maybe even hours, left to live, he must save this girl, while the one thing he's relied on all of his life fails him - his mind! | |
 |
Seelenfresser by Tumor SPV. |
 |
Fibroid Tumors and Endometriosis by Susan M. Lark (Author) Fibroid tumors and endometriosis are two increasingly prevalent conditions among women. This groundbreaking volume contains the only complete self-help program offering facts and information about the causes and diagnosis; a weekly self-evaluation process; the latest information on medical procedures; solutions that utilize vitamins, herbs, and essential fatty acids; overall diet and individual meal plans; and physical exercise. |
 |
Living with a Brain Tumor: Dr. Peter Black's Guide to Taking Control of Your Treatment by Peter Black (Author) Each year, 100,000 people in the United States are diagnosed with a brain tumor. With his new book, Dr. Peter Black fills a gap in the lay readership, providing an accessible medical resource for adult patients and their families. Dr. Black, who has operated on more than 3,000 patients with brain tumors, is uniquely qualified to discuss both clinical treatment of and research into brain tumors. This invaluable resource tells patients everything they need to know to understand and address their diagnosis, in a four-part structure: • “What is a Brain Tumor?" provides straightforward information about how brain tumors are diagnosed, the different types of tumors and how they develop, and where to go for treatment. • “Coping with Shock” addresses the emotional... |
 |
The Tumor Funambulist (Primary Contributor) |
 |
PIZZA TUMOR Funny Definition (Gotta See it to Believe it -TRUST ME, YOU'LL LAUGH) Ladies T-Shirt Pink Large by T-ShirtFrenzy The Design/Saying is printed on the front of this T-Shirt, we use the newest & best technology to print the design with great inks that are cured into the product. This new high tech way of producing garments is very fade resistant. WE DO NOT USE TRANSFERS. It is great, since you dont have that thick transfer feeling. The feel is very smooth and comfortable. T-ShirtFrenzy offers over 30,000 designs on tons of products to offer millions of variations. You can search our store for something for everyone on your gift list or shop for yourself (our personal favorite). Please contact us with questions. |
 |
Doug Ferony In Concert: Benefit for the Brain Tumor Society Starring: Doug Ferony Directed By: MJM Productions Also With: Doug Ferony (Producer), Doug Ferony (Writer) Recorded at the Paramount Center for the Arts in Peekskill, this 70 minute DVD shows Doug Ferony and his Orchestra perform such classics as Paper Moon, Too Marvelous for Words, Mack the Knife and others. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
3B Scientific Single Breast w. benign tumor by 3B Scientific |
 |
Alternative Health & Herbs Remedies Skin Tumors (external), 1-Ounce Bottle (Pack of 2) by Alternative Health & Herbs Remedies Use externally for skin tumors, skin cancer, infection, and skin disorders. |
 |
PetAlive C-Caps and DetoxPlus ComboPack by PetAlive The PetAlive ComboPack of C-Caps and DetoxPlus consists of multiple remedies that work well together to provide increased support for your pets condition. This ComboPack is effective for cancer support and systemic cleansing. The C-Caps strengthen immune system to prevent and treat cancer while the DetoxPlus cleanses the system and eliminates toxins from the body. |
| © 2009 BrightSurf.com |